Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Immunovant Inc. Common Stock (IMVT) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance

Immunovant Inc. Common StockTrade
Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade

Price performance (Past 24H)

Key statistics

Immunovant Inc. Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 20× Immunovant Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.

IMVTMFG
Market Cap
$6.62B$132.18B
Volume
1,131,3643,264,662
Sector
HealthFinancials
52-Week High
$44.96$11.45
52-Week Low
$17.03$6.09
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.72B$35.48T
Dividend Yield
—1.7%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IMVT
100% Buy0% Sell
Avg holding period · 0 Days
MFG
100% Buy0% Sell
Avg holding period · 0 Days

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →